Investigational Site Number :6420009

Bucharest 030303

0 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Type 2 Diabetes Mellitus

Studies at this site

• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation — Completed
• Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early